Primary hypothyroidism masquerading as hepatocellular necrosis.
From the School of Medicine and Population Health, University of Newcastle, Department of General Medicine, Calvary Mater Hospital, Department of Immunopathology, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre and Department of Clinical Chemistry, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW 2310, Australia.
L
L
Kasherman
From the School of Medicine and Population Health, University of Newcastle, Department of General Medicine, Calvary Mater Hospital, Department of Immunopathology, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre and Department of Clinical Chemistry, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW 2310, Australia From the School of Medicine and Population Health, University of Newcastle, Department of General Medicine, Calvary Mater Hospital, Department of Immunopathology, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre and Department of Clinical Chemistry, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW 2310, Australia.
A
A
Foy
From the School of Medicine and Population Health, University of Newcastle, Department of General Medicine, Calvary Mater Hospital, Department of Immunopathology, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre and Department of Clinical Chemistry, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW 2310, Australia From the School of Medicine and Population Health, University of Newcastle, Department of General Medicine, Calvary Mater Hospital, Department of Immunopathology, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre and Department of Clinical Chemistry, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW 2310, Australia.
A
A
Tierney
From the School of Medicine and Population Health, University of Newcastle, Department of General Medicine, Calvary Mater Hospital, Department of Immunopathology, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre and Department of Clinical Chemistry, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW 2310, Australia From the School of Medicine and Population Health, University of Newcastle, Department of General Medicine, Calvary Mater Hospital, Department of Immunopathology, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre and Department of Clinical Chemistry, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW 2310, Australia.
G E M
GE
Reeves
From the School of Medicine and Population Health, University of Newcastle, Department of General Medicine, Calvary Mater Hospital, Department of Immunopathology, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre and Department of Clinical Chemistry, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW 2310, Australia From the School of Medicine and Population Health, University of Newcastle, Department of General Medicine, Calvary Mater Hospital, Department of Immunopathology, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre and Department of Clinical Chemistry, Hunter Area Pathology Service, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW 2310, Australia huy.tran@hnehealth.nsw.gov.au.
H A
HA
Tran
D003937:Diagnosis, Differential; D058625:End Stage Liver Disease / Q000209:etiology*; D005260:Female; D020249:Hormone Replacement Therapy / Q000379:methods; D006801:Humans; D007037:Hypothyroidism / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D008099:Liver / Q000473:pathology*; D008875:Middle Aged; D009230:Myxedema / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D009336:Necrosis / Q000175:diagnosis; D013974:Thyroxine / Q000627:therapeutic use
D013974:Thyroxine